Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.
暂无分享,去创建一个
P. Heeringa | N. Maeda | R. Falk | J. Jennette | Hong Xiao | P. Hu | Y. Aratani | Minglang Zhao | Zhi Liu
[1] C. Savage,et al. New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis , 2002, Current opinion in rheumatology.
[2] D. Connolly,et al. Large-scale purification of myeloperoxidase from HL60 promyelocytic cells: characterization and comparison to human neutrophil myeloperoxidase. , 2000, Protein expression and purification.
[3] N. Maeda,et al. Severe Impairment in Early Host Defense againstCandida albicans in Mice Deficient in Myeloperoxidase , 1999, Infection and Immunity.
[4] D. Adu,et al. Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. , 1999, Kidney international.
[5] R. Falk,et al. Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[6] C. Kallenberg,et al. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. , 1998, Kidney international.
[7] R. Falk,et al. Small-vessel vasculitis. , 1997, The New England journal of medicine.
[8] C. Marsh,et al. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. , 1997, The Journal of clinical investigation.
[9] R. Dinkel,et al. The effects of dementia in German acute care hospitals. , 1997, Dementia and geriatric cognitive disorders.
[10] R. Falk,et al. ANCA small-vessel vasculitis. , 1997, Journal of the American Society of Nephrology : JASN.
[11] D. Adu,et al. IL‐1β production by human polymorphonuclear leucocytes stimulated by anti‐neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis , 1996, Clinical and experimental immunology.
[12] W. Seeger,et al. Neutrophi l Act ivat ion by Ant i-Prote inase 3 Ant ibod ies in Wegener ' s Granulomatos , 2003 .
[13] J. Warren,et al. Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes. , 1995, The Journal of laboratory and clinical medicine.
[14] C. Kallenberg,et al. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. , 1994, Kidney international.
[15] J. Pearson,et al. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. , 1992, The American journal of pathology.
[16] V. Stewart,et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.
[17] R. Falk,et al. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. , 1992, Kidney international.
[18] R. Falk,et al. Reactivity of antineutrophil cytoplasmic autoantibodies with mononuclear phagocytes , 1992, Journal of leukocyte biology.
[19] R. Terrell,et al. Antibodies Against Granule Proteins Activate Neutrophils In Vitro , 1991, Journal of leukocyte biology.
[20] R J Falk,et al. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Hoidal,et al. Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. , 1990, Blood.
[22] R. Falk,et al. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. , 1988, The New England journal of medicine.
[23] A. B. Hill. The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.